{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:18:30Z","timestamp":1792671510605,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbi.2020.10.017","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T08:11:06Z","timestamp":1603440666000},"page":"369-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease"],"prefix":"10.1016","volume":"91","author":[{"given":"Itzia","family":"Jimenez-Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Due\u00f1as-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Boza-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin C.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Deierborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Swanberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbi.2020.10.017_b0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0010","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"41","key":"10.1016\/j.bbi.2020.10.017_b0015","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1523\/JNEUROSCI.1788-16.2017","article-title":"Prying into the Prion Hypothesis for Parkinson's disease","volume":"37","author":"Brundin","year":"2017","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2020.10.017_b0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(00)80681-0","article-title":"Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression","volume":"4","author":"Chang","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2020.10.017_b0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflam."},{"issue":"3","key":"10.1016\/j.bbi.2020.10.017_b0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J. Neuroinflam."},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12974-018-1202-9","article-title":"Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J Neuroinflam."},{"issue":"2","key":"10.1016\/j.bbi.2020.10.017_b0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect alpha-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease","volume":"14","author":"George","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.bbi.2020.10.017_b0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bbi.2020.10.017_b0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"23","key":"10.1016\/j.bbi.2020.10.017_b0065","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2020.10.017_b0070","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.180.5.3289","article-title":"Vra4 congenic rats with allelic differences in the class II transactivator gene display altered susceptibility to experimental autoimmune encephalomyelitis","volume":"180","author":"Harnesk","year":"2008","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bbi.2020.10.017_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027109","article-title":"Evidence for more than one Parkinson's disease-associated variant within the HLA region","volume":"6","author":"Hill-Burns","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbi.2020.10.017_b0080","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2020.10.017_b0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2017.07.016","article-title":"Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to alpha-synuclein-induced dopaminergic neurodegeneration","volume":"106","author":"Jimenez-Ferrer","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2020.10.017_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/npjparkd.2015.2","article-title":"Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson's Disease: an observational and case-control study","volume":"1","author":"Kannarkat","year":"2015","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.bbi.2020.10.017_b0095","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbi.2020.10.017_b0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbi.2020.10.017_b0105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nbd.2011.05.001","article-title":"Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat","volume":"43","author":"Kordower","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2020.10.017_b0110","doi-asserted-by":"crossref","first-page":"31701","DOI":"10.1038\/srep31701","article-title":"Identification of multiple QTLs linked to neuropathology in the engrailed-1 heterozygous mouse model of Parkinson's disease","volume":"6","author":"Kurowska","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbi.2020.10.017_b0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000072500","article-title":"HLA typing and Parkinson's disease","volume":"50","author":"Lampe","year":"2003","journal-title":"Eur. Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2020.10.017_b0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"issue":"30","key":"10.1016\/j.bbi.2020.10.017_b0125","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1523\/JNEUROSCI.23-30-09817.2003","article-title":"Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS","volume":"23","author":"Lidman","year":"2003","journal-title":"J. Neurosci."},{"issue":"47","key":"10.1016\/j.bbi.2020.10.017_b0130","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.bbi.2020.10.017_b0135","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bbi.2020.10.017_b0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.celrep.2017.09.039","article-title":"Temporal tracking of microglia activation in neurodegeneration at single-cell resolution","volume":"21","author":"Mathys","year":"2017","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.bbi.2020.10.017_b0145","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbi.2020.10.017_b0150","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF00689592","article-title":"Expression of the histocompatibility glycoprotein HLA-DR in neurological disease","volume":"76","author":"McGeer","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2020.10.017_b0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.isci.2019.05.039","article-title":"CD4 T cells induce a subset of MHCII-expressing microglia that attenuates Alzheimer pathology","volume":"16","author":"Mittal","year":"2019","journal-title":"iScience"},{"issue":"5 Pt 2","key":"10.1016\/j.bbi.2020.10.017_b0160","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2020.10.017_b0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","article-title":"Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration","volume":"82","author":"Paumier","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bbi.2020.10.017_b0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-0270(80)90021-7","article-title":"AChE-stained horizontal sections of the rat brain in stereotaxic coordinates","volume":"3","author":"Paxinos","year":"1980","journal-title":"J. Neurosci. Methods"},{"issue":"7556","key":"10.1016\/j.bbi.2020.10.017_b0175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"Alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbi.2020.10.017_b0180","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1084\/jem.20160368","article-title":"Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease","volume":"213","author":"Rey","year":"2016","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease","volume":"5","author":"Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbi.2020.10.017_b0190","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0092-8674(05)80090-X","article-title":"Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)","volume":"75","author":"Steimle","year":"1993","journal-title":"Cell"},{"issue":"7660","key":"10.1016\/j.bbi.2020.10.017_b0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"issue":"41","key":"10.1016\/j.bbi.2020.10.017_b0205","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","article-title":"Parkinson's disease is not simply a prion disorder","volume":"37","author":"Surmeier","year":"2017","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2020.10.017_b0210","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ng1544","article-title":"MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction","volume":"37","author":"Swanberg","year":"2005","journal-title":"Nat. Genet."},{"issue":"39","key":"10.1016\/j.bbi.2020.10.017_b0215","doi-asserted-by":"crossref","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbi.2020.10.017_b0225","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-018-1286-2","article-title":"Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease","volume":"15","author":"Williams","year":"2018","journal-title":"J. Neuroinflam."},{"issue":"5","key":"10.1016\/j.bbi.2020.10.017_b0230","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"Wissemann","year":"2013","journal-title":"Am. J. Hum. Genet."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120323679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120323679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:07:19Z","timestamp":1760170039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159120323679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":46,"alternative-id":["S0889159120323679"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.10.017","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}